Source:http://linkedlifedata.com/resource/pubmed/id/10972629
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2000-12-11
|
pubmed:abstractText |
This article reviews the clinical manifestations of mitochondrial toxicity associated with the use of nucleoside analog reverse transcriptase inhibitors (NRTIs) and outlines strategies to manage these sequelae.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0149-2918
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
911-36; discussion 898
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2000
|
pubmed:articleTitle |
Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity.
|
pubmed:affiliation |
Chelsea and Westminster Hospital, London, United Kingdom. gm@moyleg.demon.co.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|